Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Abstract
Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional absorption and bioavailability assessments, and the body-weight regressions built upon them, implicitly assume the portal route and seldom quantify the lymphatic contribution, even though, for suitable compounds, it can represent a substantial fraction of systemic exposure [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“This route becomes quantitatively relevant only for compounds that combine high lipophilicity with appreciable long-chain triglyceride solubility, for which a log P greater than 5 and a lipid solubility above approximately 50 mg/g are commonly cited as approximate thresholds [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“The extent of transport is highly sensitive to prandial state and to the type and quantity of co-administered lipid, which differ across preclinical study designs and between the fasted conditions typical of first-in-human protocols and the fed conditions under which lymphatic transport is greatest [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“This is especially the case when potent, but highly lipophilic, drug candidates arise from complex chemical scaffolds and multiple high-throughput activity screen”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,648
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401 · cited 1×
“In addition to the potential effect of lipidic excipients (primarily surfactants) on P-gp-mediated efflux, Benet and co-workers have recently suggested that high-fat meals could inhibit P-g”
BackgroundSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Cited by
Items 301–400 of 1,003
Benito-Gallo, P., Franceschetto, A., Wong, J. C. M., Marlow, M., Zann, V., Scholes, P., & Gershkovich, P. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.027 · Cited by 101
Genetic Variations Associated with Vitamin A Status and Vitamin A Bioavailability
Borel, P., & Desmarchelier, C. (2017) · Nutrients · doi:10.3390/nu9030246 · Cited by 100
“Since mixed micelles are assumed to dissociate in the unstirred water layer adjacent to the enterocyte apical membrane [24], VA incorporated in mixed micelles, i.”
BackgroundLee, S. H., Kim, H. Y., Back, S. Y., & Han, H. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1418854 · Cited by 100
Utility of Pickering emulsions in improved oral drug delivery
Tai, Z., Huang, Y., Zhu, Q., Wu, W., Yi, T., Chen, Z., & Lü, Y. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.012 · Cited by 100
Majeed, H., Antoniou, J., Hategekimana, J., Sharif, H. R., Haider, J., Liu, F., Ali, B., Liang, R., Ma, J., & Zhong, F. (2015) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2015.07.009 · Cited by 100
Han, S., Quach, T., Hu, L., Wahab, A., Charman, W. N., Stella, V. J., Trevaskis, N. L., Simpson, J. S., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.031 · Cited by 100
“The lymphatic system is themain conduit for the transport of dietary lipids (such as triglyceride, TG) and lipid soluble vitamins from the intestine to the systemic circulation [8,9].”
BackgroundSelf-citationHens, B., Brouwers, J., Corsetti, M., & Augustijns, P. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.05.023 · Cited by 100
Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases
Fernandez, S., Rodier, J.-D., Ritter, N., Mahler, B., Demarne, F., Carrière, F., & Jannin, V. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.05.006 · Cited by 99
Sandra, S., Decker, E. A., & McClements, D. J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf800741w · Cited by 99
Estimation of effective intestinal membrane permeability considering bile micelle solubilisation
Sugano, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.001 · Cited by 99
Mouhid, L., Corzo‐Martínez, M., Torres, C. F., Vázquez, L., Reglero, G., Fornari, T., & de Molina, A. R. (2017) · Journal of Oncology · doi:10.1155/2017/7351976 · Cited by 100
Modeling Kinetics of Subcellular Disposition of Chemicals
Baláž, Š. (2009) · Chemical Reviews · doi:10.1021/cr030440j · Cited by 98
Carrière, F. (2015) · Biochimie · doi:10.1016/j.biochi.2015.11.016 · Cited by 98
Lipidic prodrug approach for improved oral drug delivery and therapy
Marković, M., Ben‐Shabat, S., Keinan, S., Aponick, A., Zimmermann, E. M., & Dahan, A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21533 · Cited by 97
“By comparison, the blood capillaries contain tight junctions and the continuous basal membrane that restrict the permeability of large colloids (Figure 4).(68,69) The collection of lacteals and submucosal”
BackgroundEffects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro
Christiansen, A., Backensfeld, T., Denner, K., & Weitschies, W. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.033 · Cited by 97
Teiten, M.-H., Mack, F., Debbab, A., Aly, A. H., Dicato, M. A., Proksch, P., & Diederich, M. F. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.024 · Cited by 97
Past and future evolution in colloidal drug delivery systems
Boyd, B. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.69 · Cited by 88
“Lipids, self-emulsifying oral formulations [138]”
Arora, D., & Jaglan, S. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.06.003 · Cited by 97
Biological fate of ingested lipid-based nanoparticles: current understanding and future directions
Wang, T., & Luo, Y. (2019) · Nanoscale · doi:10.1039/c9nr03025e · Cited by 96
Wang, Y., Zhang, T., Liu, R., Chang, M., Wei, W., Jin, Q., & Wang, X. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111058 · Cited by 96
A tissue‐engineered model of the intestinal lacteal for evaluating lipid transport by lymphatics
Dixon, J. B., Raghunathan, S., & Swartz, M. A. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22337 · Cited by 96
“In order to establish the usefulness of such a model for studying both lipid uptake and drug delivery (Porter et al., 2007; Trevaskis et al., 2008), we demonstrate its relevance to the in vivo environment and report baseline measurements of FFA and lipid transport through this in vitro model.”
BackgroundYin, J., Hou, Y., Yin, Y., & Song, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144615 · Cited by 96
“NLCs belong to the scope of lipid-based formulations, which can optimize the oral delivery of lipophilic drugs by solubilizing the drug in the intestinal milieu, recruiting intestinal lymphatic drug transport and altering enterocytebased drug transport and disposition.(28) Meanwhile, lipolysis of lipid nanoparticles a…”
BackgroundFormation of Highly Organized Nanostructures during the Digestion of Milk
Salentinig, S., Phan, S., Khan, J., Hawley, A. M., & Boyd, B. J. (2013) · ACS Nano · doi:10.1021/nn405123j · Cited by 95
“bioactivemolecules contained in themilk to the circulatory system of the body.(9) 14 It is a”
Chokshi, N. V., Khatri, H. N., & Patel, M. M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1506472 · Cited by 96
“Through lymphatic circulation, these lipid nanoparticulate systems gets delivered into systemic circulation thereby enhancing the bioavailability of drugs) via subclavian and jugular veins, thus bypassing hepatic first-pass metabolism of drugs [8,9].”
BackgroundPobirk, A. Z., Berginc, K., Kristl, A., & Gašperlin, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.055 · Cited by 94
Impact of different biopolymer networks on the digestion of gastric structured emulsions
Wooster, T. J., Day, L., Xu, M., Golding, M., Øiseth, S. K., Keogh, J. B., & Clifton, P. M. (2013) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2013.09.009 · Cited by 94
Piazzini, V., Monteforte, E., Luceri, C., Bigagli, E., Bilia, A. R., & Bergonzi, M. C. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1256002 · Cited by 94
“Lipid carriers promote absorption through GI tract, by ameliorating the solubility of drug and by increasing the solubilization capacity of the GI fluids (Porter et al., 2007, 2008).”
BackgroundNanostructured lipid carriers as a favorable delivery system for β-carotene
Pezeshki, A., Hamishehkar, H., Ghanbarzadeh, B., Fathollahy, I., Nahr, F. K., Heshmati, M. K., & Mohammadi, M. (2018) · Food Bioscience · doi:10.1016/j.fbio.2018.11.004 · Cited by 94
Han, S., Yao, T.-T., Zhang, X., Gan, L., Zhu, C., Yu, H., & Gan, Y. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.001 · Cited by 93
Feeney, O. M., Williams, H. D., Pouton, C. W., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.037 · Cited by 93
Self-citationMiao, Y., Lin, Y., Chen, K., Luo, P., Chuang, S., Yu, Y., Tai, H., Chen, C., Lin, K., & Sung, H. (2021) · Advanced Materials · doi:10.1002/adma.202104139 · Cited by 84
Chaudhuri, A., Kumar, D. N., Shaik, R. A., Eid, B. G., Abdel‐Naim, A. B., Md, S., Ahmad, A., & Agrawal, A. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710068 · Cited by 92
Thomas, N., Müllertz, A., Graf, A., & Rades, T. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23054 · Cited by 92
Mulet, X., Kennedy, D. F., Conn, C. E., Hawley, A. M., & Drummond, C. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.029 · Cited by 92
Polyelectrolyte complexes as prospective carriers for the oral delivery of protein therapeutics
Bourganis, V., Karamanidou, T., Kammona, O., & Kiparissides, C. A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.005 · Cited by 93
Khurana, R. K., Bansal, A. K., Beg, S., Burrow, A. J., Katare, O. P., Singh, K. K., & Singh, B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.044 · Cited by 91
“Together lipids, surfactants and absorption enhancers facilitate the increased bioavailability because of nanostructured NLCs, micellar solubilisation in intestinal milieu, followed by increased intestinal transport through transcellular and paracellular pathways (Porter et al., 2007).”
BackgroundBadran, M. M., Taha, E. I., Tayel, M. M., & Al‐Suwayeh, S. A. (2013) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2013.10.015 · Cited by 91
Day, J. P. R., Rago, G., Domke, K. F., Velikov, K. P., & Bonn, M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102069d · Cited by 84
Speybroeck, M. V., Williams, H. D., Nguyen, T., Anby, M. U., Porter, C. J. H., & Augustijns, P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300298z · Cited by 91
Self-citationKanwal, T., Kawish, M., Maharjan, R., Ghaffar, I., Ali, H. S., Imran, M. A., Perveen, S., Saifullah, S., Sımjee, S. U., & Shah, M. R. (2019) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2019.111098 · Cited by 90
Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib
Chavan, R. B., Modi, S. R., & Bansal, A. K. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.011 · Cited by 90
Xu, G., Li, L., Bao, X., & Yao, P. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100569 · Cited by 89
Using in Vitro and in Vivo Models To Evaluate the Oral Bioavailability of Nutraceuticals
Ting, Y., Zhao, Q., Xia, C., & Huang, Q. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5047464 · Cited by 89
Christophersen, P. C., Christiansen, M. L., Holm, R., Kristensen, J., Jacobsen, J. B., Abrahamsson, B., & Müllertz, A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.007 · Cited by 89
“After initiation of the duodenal step, the cinnarizine amount in the aqueous phase was relatively constant for SNEDDS-C and the SNEDDS-T, while it declined rapidly for the conventional tablet demonstrating that the lipid and surfactant components of the SNEDDS-C and SNEDDS-T enhance the cinnarizine solubilization in t…”
BackgroundBinary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin
Shangguan, M., Lü, Y., Qi, J., Han, J., Tian, Z., Xie, Y., Hu, F., Yuan, H., & Wu, W. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213485141 · Cited by 89
“It seems that lipid-based drug delivery systems are more promising in improving the oral absorption of SM owing to their specific absorption-enhancing mechanisms.(18) However, the development of lipid-based SM delivery systems is highly lagged due to, at least partly, formulation problems associated with solubilizatio…”
BackgroundFranco, V., Gershkovich, P., Perucca, E., & Bialer, M. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00931-w · Cited by 88
Block copolymers at interfaces: Interactions with physiological media
Torcello‐Gómez, A., Wulff-Pérez, M., Gálvez-Ruiz, M. J., Martín-Rodríguez, A., Cabrerizo-Vílchez, M. Á., & Maldonado‐Valderrama, J. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.10.027 · Cited by 88
Neupane, Y. R., Sabir, M. D., Ahmad, N., Ali, M., & Kohli, K. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/41/415102 · Cited by 87
Scheuble, N., Schaffner, J., Schumacher, M., Windhab, E. J., Liu, D., Parker, H. L., Steingoetter, A., & Fischer, P. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b02637 · Cited by 87
Sensing of Dietary Lipids by Enterocytes: A New Role for SR-BI/CLA-1
Béaslas, O., Cueille, C., Delers, F., Château, D., Chambaz, J., Rousset, M., & Carrière, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004278 · Cited by 87
“Inter-prandial lipid micelles (IPM) were prepared as PPM but, according to physiological conditions [19], were devoid of oleic acid and 2-monooleoylglycerol.”
MethodQureshi, M. J., Chitneni, M., & Kian, W. G. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.003 · Cited by 87
Lipid-Based Oral Formulation Strategies for Lipophilic Drugs
Patel, V., Lalani, R., Bardoliwala, D., Ghosh, S., & Misra, A. R. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1188-8 · Cited by 87
Tran, P., & Park, J. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00516-0 · Cited by 86
Steingoetter, A., Radović, T., Buetikofer, S., Curcic, J., Menne, D., Fried, M., Schwizer, W., & Wooster, T. J. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.100263 · Cited by 86
Impact of Protein Gel Porosity on the Digestion of Lipid Emulsions
Sarkar, A., Juan, J.-M., Kolodziejczyk, E., Acquistapace, S., Donato, L., & Wooster, T. J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03700 · Cited by 86
Price, D. J., Ditzinger, F., Koehl, N. J., Janković, S., Τσακιρίδου, Γ., Nair, A., Holm, R., Kuentz, M., Dressman, J., & Saal, C. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12927 · Cited by 86
Alqahtani, S., Simon, L. C., Astete, C. E., Alayoubi, A. Y., Sylvester, P. W., Nazzal, S., Shen, Y., Xu, Z., Kaddoumi, A., & Sabliov, C. M. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.12.083 · Cited by 85
Cubosomes of dapsone enhanced permeation across the skin
Nithya, R., Jerold, P., & Siram, K. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.09.002 · Cited by 85
Solubility and Bioavailability Enhancement of Oridonin: A Review
Zhang, Y., Wang, S., Dai, M., Nai, J., Zhu, L., & Sheng, H. (2020) · Molecules · doi:10.3390/molecules25020332 · Cited by 84
“After oral administration of NLCs, lipids are digested in the gastrointestinal (GI) tract, increasing the residence time and absorption of the oral anti-cancer drugs [100].”
BackgroundTailoring the digestion of structured emulsions using mixed monoglyceride–caseinate interfaces
Day, L., Golding, M., Xu, M., Keogh, J. B., Clifton, P. M., & Wooster, T. J. (2013) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2013.09.019 · Cited by 84
Simović, S., He, H. Z., Song, Y., Davey, A. K., Rades, T., & Prestidge, C. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.008 · Cited by 84
Singla, P., Chabba, S., & Mahajan, R. K. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.05.043 · Cited by 84
Khan, S., Yar, M. S., Fazil, M., Baboota, S., & Ali, J. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.017 · Cited by 84
Nanostructure lipid carriers: A modish contrivance to overcome the ultraviolet effects
Jain, P., Rahi, P., Pandey, V., Asati, S., & Soni, V. (2017) · Egyptian Journal of Basic and Applied Sciences · doi:10.1016/j.ejbas.2017.02.001 · Cited by 84
Lind, M. L., Jacobsen, J., Holm, R., & Müllertz, A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.07.003 · Cited by 84
Self-microemulsifying drug-delivery system: ongoing challenges and future ahead
Rajpoot, K., Tekade, M., Pandey, V., Sreeharsha, N., Youngren-Ortiz, S. R., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00009-0 · Cited by 83
Coenzyme Q10: Novel Formulations and Medical Trends
Pastor‐Maldonado, C. J., Suarez-Rivero, J. M., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., Talaverón-Rey, M., & Sánchez-Alcázar, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228432 · Cited by 84
Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9824-7 · Cited by 83
Abuasal, B., Lucas, C., Peyton, B., Alayoubi, A. Y., Nazzal, S., Sylvester, P. W., & Kaddoumi, A. (2012) · Lipids · doi:10.1007/s11745-012-3655-4 · Cited by 83
“Mixed micelles (MM) are the end product of intestinal digestion that is most readily available for absorption [30].”
Dahan, A., Duvdevani, R., Shapiro, I., Elmann, A., Finkelstein, E., & Hoffman, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.025 · Cited by 83
Yaghmur, A., Sartori, B., & Rappolt, M. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp01036g · Cited by 83
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82
“4,5 Currently, less than 4% of commercial drug products are available as LBFs. 6 A complicating factor in the development of LBFs is the selection of appropriate excipients due to poor predictions of their in vivo performance.”
Harshita, Barkat, M. A., Rizwanullah, M., Beg, S., Pottoo, F. H., Siddiqui, S., & Ahmad, F. J. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1304-4 · Cited by 82
Structured edible lipid-based particle systems for oral drug-delivery
Ashkar, A., Sosnik, A., & Davidovich‐Pinhas, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107789 · Cited by 82
Shete, H. K., Chatterjee, S., De, A., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.036 · Cited by 82
Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS
Thi, T. D., Speybroeck, M. V., Barillaro, V., Martens, J. A., Annaert, P., Augustijns, P., Humbeeck, J. V., Vermant, J., & den Mooter, G. V. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.09.012 · Cited by 82
Dadkhodazade, E., Mohammadi, A., Shojaee‐Aliabadi, S., Mortazavian, A. M., Mirmoghtadaie, L., & Hosseini, S. M. (2018) · Food Biophysics · doi:10.1007/s11483-018-9546-3 · Cited by 82
Jang, J. Y., Koh, Y. J., Lee, S.-H., Lee, J., Kim, K., Kim, D., Koh, G. Y., & Yoo, O. J. (2013) · Blood · doi:10.1182/blood-2013-01-478941 · Cited by 81
“Lymphatic vessels in intestinal villi are actively involved in transport of absorbed dietary lipids as form of colloidal lipoproteins and certain highly lipophilic compounds (for example, lipid-soluble vitamins and drugs) from absorptive epithelial cells to systemic circulation via mesenteric collecting lymphatic vess…”
BackgroundTan, A., Eskandar, N. G., Rao, S., & Prestidge, C. A. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0172-9 · Cited by 81
“, dose/solubility ratio of >250ml or water solubility of <100μg/ml) [1–3].”
BackgroundPoquet, L., & Wooster, T. J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500883 · Cited by 81
Yang, Y. R., Xiao, H., & McClements, D. J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00955 · Cited by 81
Structural characterization of multilamellar liposomes coencapsulating curcumin and vitamin D3
Chaves, M. A., Filho, P. L. O., Jange, C. G., Sinigaglia‐Coimbra, R., Oliveira, C. L. P., & Pinho, S. C. (2018) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2018.04.018 · Cited by 81
Characteristics and Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Queiroz, M. D. C. V., & Muehlmann, L. A. (2024) · Journal of Nanotheranostics · doi:10.3390/jnt5040012 · Cited by 80
“Therefore, by utilizing this property of the lymphatic system, the absorption of lipidic molecules can be facilitated, thereby bypassing the portal circulation [48].”
Sachs‐Barrable, K., Lee, S. D., Wasan, E. K., Thornton, S. J., & Wasan, K. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.042 · Cited by 80
Food-associated stimuli enhance barrier properties of gastrointestinal mucus
Yıldız, H., Speciner, L., Ozdemir, C., Cohen, D. E., & Carrier, R. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.118 · Cited by 80
“The influence of lipids on orally delivered drug compound absorption across intestinal mucosa originates in part from colloidal structures the lipids form [6].”
Self‐Assembled Nanomedicines for Anticancer and Antibacterial Applications
Zhou, L., Qiu, T. A., Lv, F., Liu, L., Ying, J., & Wang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800670 · Cited by 80
Mariño‐Ocampo, N., Dibona‐Villanueva, L., Escobar‐Álvarez, E., Díaz, D. G., Zúñiga‐Núñez, D., Fuentealba, D., & Robinson‐Duggon, J. (2022) · Photochemistry and Photobiology · doi:10.1111/php.13749 · Cited by 80
Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes
Moholkar, D. N., Kandimalla, R., Gupta, R. C., & Aqil, F. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216220 · Cited by 79
Ravi, P. R., Vats, R., Dalal, V., Gadekar, N., & Aditya, N. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.850710 · Cited by 79
Yang, G., Zhao, Y., Zhang, Y., Dang, B., Liu, Y., & Feng, N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92665 · Cited by 79
Zhang, W., Li, Y., Zou, P., Wu, M., Zhang, Z., & Zhang, T. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9928-8 · Cited by 79
Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.002 · Cited by 78
Zhou, X., Zhang, X., Ye, Y., Zhang, T., Wang, H., Ma, Z., & Wu, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.068 · Cited by 78
Vertzoni, M., Markopoulos, C., Symillides, M., Goumas, C., Imanidis, G., & Reppas, C. I. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200479f · Cited by 78
Li, L., Qi, C., Wang, X., Jin, Q., & McClements, D. J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04721 · Cited by 78
Parrott, N. J., Yu, L. J., Takano, R., Nakamura, M., & Morcos, P. N. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9957-3 · Cited by 77
de Sousa, V. P., Monteiro, Lione, do Carmo, F. A., Amaral, Henriques-Silva, Nasciutti, L. E., Castro, H. C., Rodrigues, C. R., & Cabral, L. M. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36479 · Cited by 77
“Moreover, these surfactants are classified as promoters of permeation because they form pores in the cell membrane (enterocytes in this model), which increase drug permeation across the intestinal epithelium after oral administration.(35) The dapsone solution containing the Tween 80 and Span 80 surfactants did not pro…”
Yeap, Y. Y., Trevaskis, N. L., & Porter, C. J. H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1104-6 · Cited by 77
“The model LCFA colloids used in this study were chosen to be representative of the post-digestion lipid colloidal phases likely responsible for the presentation of solubilized drug to the absorptive membrane (2,23).”
Self-citationTrevaskis, N. L., Hu, L., Caliph, S. M., Han, S., & Porter, C. J. H. (2015) · Journal of Visualized Experiments · doi:10.3791/52389 · Cited by 77
Self-citationCholesterol Transport Revisited: A New Turbo Mechanism to Drive Cholesterol Excretion
de Boer, J. F., Kuipers, F., & Groen, A. K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.11.006 · Cited by 78
“The mixed micelles then carry the cholesterol through the unstirred water layer [21] to the brush border membrane of the intestinal epithelium.”
Metadata
- Authors
- Porter, C. J. H., Trevaskis, N. L., & Charman, W. N.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 231-248
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069235788
- Cited by
- 1,824
- References
- 253
- Citations by year
- 2026: 88 · 2025: 87 · 2024: 67 · 2023: 89 · 2022: 119 · 2021: 108 · 2020: 140 · 2019: 101 · 2018: 117 · 2017: 121 · 2016: 125 · 2015: 119 · 2014: 120 · 2013: 128 · 2012: 94
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based drug delivery, oral bioavailability, lipophilic drugs, poorly water-soluble drugs, lipid excipients, first-pass metabolism, lipid-based formulations
- MeSH terms
- Administration, Oral, Animals, Pharmaceutical Preparations, Excipients, Humans, Intestinal Absorption, Lipids, Drug Design, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.